Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps

Clin Immunol. 2023 Oct:255:109714. doi: 10.1016/j.clim.2023.109714. Epub 2023 Jul 30.

Abstract

Beta-2 glycoprotein I (β2GPI) is a phospholipid-binding plasma protein and prominent autoantigen in antiphospholipid syndrome (APS). Here, we tested the hypothesis that β2GPI might bind to not only phospholipids, but also cell-free DNA and neutrophil extracellular traps (NETs). We report that β2GPI interacts with cell-free DNA from different species, as well as NETs, in a dose-dependent manner, retarding their migration in an agarose-gel electrophoretic mobility shift assay. We confirm the direct binding interaction of β2GPI with DNA and NETs by ELISA. We also demonstrate that β2GPI colocalizes with NET strands by immunofluorescence microscopy. Finally, we provide evidence that β2GPI-DNA complexes can be detected in the plasma of APS patients, where they positively correlate with an established biomarker of NET remnants. Taken together, our findings indicate that β2GPI interacts with DNA and NETs, and suggest that this interaction may play a role as a perpetuator and/or instigator of autoimmunity in APS.

Keywords: Antiphospholipid antibodies; Antiphospholipid syndrome; DNA; Lupus; Neutrophil extracellular traps; beta-2 glycoprotein I.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiphospholipid Syndrome* / immunology
  • Autoantigens* / immunology
  • DNA* / immunology
  • Extracellular Traps* / immunology
  • Extracellular Traps* / metabolism
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neutrophils / immunology
  • beta 2-Glycoprotein I* / immunology

Substances

  • beta 2-Glycoprotein I
  • Autoantigens
  • DNA